Key result
Unstable plaques display ~4800 differentially expressed genes vs stable plaques, driven by sheddase upregulation.
Population
Human carotid atherosclerotic plaque samples from 4 patients obtained from the Gene Expression Omnibus…
Comparison
Transcriptomic profiling of unstable plaques vs Transcriptomic profiling of stable plaques
Design
Preclinical
Authors
Loading...
Integrative transcriptomics reveals that the sheddase pathway and extracellular matrix degradation are key molecular drivers of atherosclerotic plaque instability, offering potential new therapeutic targets.
Observational (n=4)
p-value: p=< 0.05
Integrative transcriptomics reveals that the sheddase pathway and extracellular matrix degradation are key molecular drivers of atherosclerotic plaque instability, offering potential new therapeutic targets.
Alahmadi et al. (2026) conducted an observational in Atherosclerosis (n=4). Unstable plaque regions vs. Stable plaque regions was evaluated on Differentially expressed genes (DEGs) (p=< 0.05). Unstable atherosclerotic plaques exhibited 4792 differentially expressed genes compared to stable plaques (P<0.05), with the sheddase pathway identified as a significantly upregulated driver.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: